Arch Biopartners completes private placement

Infectious disease and cancer company Arch Biopartners Inc. (TSX-V:ARCH; OTCBB:FOIFF) raised C$400,000 ($305,040) through the sale of 1 million shares at C$0.40 in a non-brokered private placement on...